[1]Pontisso P, Vidalino L, Quarta S, et al.Biological and clinical im-plications of HBV infection in peripheral blood mononuclearcells[J].Autoimmun Rev, 2008, 8 (1) ∶13-17.
|
[2]Lianq R.How I treat and monitor viral hepatitis B infection in pa-tients receiving intensive immunosuppressive therapies or undergoinghematopoietic stem cell[J].Blood, 2009, 113 (14) ∶3147-3153.
|
[3]Cariani E, Pelizzari AM, Rodella A, et al.Immune-mediated hep-atitis-associated aplastic anemia caused by the emergence of a mu-tant hepatitis B virus undetectable by standard assays[J].Hepatol, 2007, 46 (4) ∶743-747.
|
[4] 中华医学会.慢性乙型肝炎防治指南[J].临床肝胆病杂志, 2006, 22 (1) ∶3-15.
|
[5]Kimua T, Minamiguchi H, Wang J, et al.Impaired stem cell functionof CD34+cell selected by tow different imminomagnectic beads sys-tems[J].Leukemia, 2004, 18 (3) ∶566-574.
|
[6]Ali BA, Huang TH, SalemHH, et al.Salem.Expression of hepatitisB virus genes in early embryonic cells originated from hamster ovaand human spermatozoa transfected with the complete viralgenome[J].Asian J Androl, 2006, 8 (3) ∶273-279.
|
[7]Weissman IL.Stem cell:unit of development, unit of regeneration, and units in evolution[J].Cell, 2000, 100 (1) ∶157-168.
|
[8]Spaggiari GM, Abdelrazik H, Becchetti F, et al.Mesenchymal stemcells (MSC) inhibit monocyte-derived dendritic cell (DC) matura-tion and function by selectively interfering with the generation of im-mature DCs:central role of MSC-derived prostaglandin E2[J].Blood, 2009, 113 (26) ∶6576-6583.
|
[9]Vildózola Gonzales H, Salinas JL, et al.Natural history of chronichepatitis B virus infection[J].Rev Gastroenterol Peru, 2009, 29 (2) ∶147-157.
|